Alligator Bioscience names CFO Johan Giléus CEO effective Jan. 1, 2027

Bitget2026/10/04 13:50

Alligator Bioscience named CFO Johan Giléus as CEO, effective Jan. 1, 2027. Outgoing CEO Søren Bregenholt will step down at year-end 2026. Giléus will hold both CEO and CFO roles as the company narrows focus to its financial interest in HLX22. Giléus joined Alligator as CFO in August 2024, following a career at Deloitte Sweden focused on M&A and financial reporting. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alligator Bioscience AB published the original content used to generate this news brief on October 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

BUZZ-Akamai Technologies shares fall after announcing $2.2 billion convertible bond offering

路透社•2026/11/09 12:23

Updated version 1 – KKR achieves record-high profits as asset sales and management fees surge

路透社•2026/11/09 12:17

BUZZ – US Stock Market Updates: Nvidia, Genmab, Eli Lilly

路透社•2026/11/09 12:16

BUZZ-Sable Offshore shares fall as refinery shutdown hampers crude sales, putting pressure on cash flow

路透社•2026/11/09 12:16